Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.325 USD | -7.19% | -47.78% | -82.49% |
02:13pm | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
02:13pm | Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.49% | 162M | |
+3.80% | 108B | |
+11.17% | 104B | |
+1.28% | 22.33B | |
-12.80% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.63% | 17.64B | |
+3.79% | 14.05B | |
+37.36% | 12.51B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- HC Wainwright Downgrades RAPT Therapeutics to Neutral From Buy